Stockscreener 앱 받기
4.94
0.80%
-0.04
전일 마감가:
$4.98
열려 있는:
$4.92
하루 거래량:
8,975
Relative Volume:
0.04
시가총액:
$13.22M
수익:
-
순이익/손실:
$-58.52M
주가수익비율:
-2.3636
EPS:
-2.09
순현금흐름:
$-45.03M
1주 성능:
-3.70%
1개월 성능:
-1.98%
6개월 성능:
+568.47%
1년 성능:
+238.36%
1일 변동 폭
$4.814
$4.94
1주일 범위
$4.814
$5.1834
52주 변동 폭
$0.224
$6.42
Nextcure Inc Stock (NXTC) Company Profile
명칭
Nextcure Inc
전화
240-399-4900
주소
9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD
NXTC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NXTC
Nextcure Inc
|
4.94 | 13.19M | 0 | -58.52M | -45.03M | -2.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Nextcure Inc Stock (NXTC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-11-04 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2022-03-01 | 개시 | Ladenburg Thalmann | Buy |
| 2021-03-05 | 업그레이드 | Truist | Hold → Buy |
| 2021-01-15 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2020-07-16 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2020-07-13 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2020-07-13 | 다운그레이드 | SunTrust | Buy → Hold |
| 2020-06-01 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2020-06-01 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2020-05-26 | 개시 | JMP Securities | Mkt Outperform |
| 2020-03-24 | 개시 | The Benchmark Company | Buy |
| 2020-03-02 | 개시 | ROTH Capital | Buy |
| 2020-01-13 | 개시 | SunTrust | Buy |
| 2019-12-05 | 개시 | Needham | Buy |
| 2019-11-26 | 개시 | BTIG Research | Buy |
| 2019-07-09 | 개시 | BofA/Merrill | Buy |
| 2019-06-03 | 개시 | Morgan Stanley | Overweight |
| 2019-06-03 | 개시 | Piper Jaffray | Overweight |
모두보기
Nextcure Inc 주식(NXTC)의 최신 뉴스
Chart based analysis of NextCure Inc. trendsPortfolio Growth Summary & Consistent Return Investment Signals - Newser
Is now a turning point for NextCure Inc.2025 Valuation Update & Fast Exit/Entry Strategy Plans - Newser
Technical analysis overview for NextCure Inc. stock2025 Technical Patterns & Safe Capital Growth Trade Ideas - Newser
Ranking NextCure Inc. among high performing stocks via toolsJuly 2025 Outlook & Stepwise Trade Signal Implementation - Newser
NextCure to Present at the H.C. Wainwright 27th Annual Global Investment Conference - The Manila Times
Cancer Drug Developer NextCure Scheduled for H.C. Wainwright Investment Conference Presentation - Stock Titan
Applying big data sentiment scoring on NextCure Inc.Quarterly Trade Report & AI Forecasted Entry and Exit Points - Newser
Heatmap analysis for NextCure Inc. and competitors2025 Sector Review & Safe Investment Capital Preservation Plans - Newser
Is NextCure Inc. forming bullish engulfing patternsPortfolio Risk Report & Long Hold Capital Preservation Tips - khodrobank.com
Can NextCure Inc. stock outperform in a bear marketWeekly Earnings Recap & Safe Capital Growth Tips - khodrobank.com
Relative strength of NextCure Inc. in sector analysisWeekly Stock Analysis & Verified Chart Pattern Signals - Newser
Using fundamentals and technicals on NextCure Inc.Trade Exit Summary & Real-Time Stock Entry Alerts - Newser
Pattern recognition hints at NextCure Inc. upsideQuarterly Portfolio Report & Smart Money Movement Alerts - Newser
Will NextCure Inc. see short term momentum2025 Market Outlook & Fast Exit and Entry Strategy Plans - Newser
How to recover losses in NextCure Inc. stock2025 Market Outlook & Long-Term Safe Return Strategies - Newser
Understanding NextCure Inc.’s price movementRisk Management & Weekly Chart Analysis and Trade Guides - Newser
What data driven models say about NextCure Inc.’s futureWeekly Trend Recap & Low Risk Profit Maximizing Plans - Newser
NextCure Inc. stock daily chart insights2025 Price Targets & Smart Money Movement Alerts - Newser
Is NextCure Inc. vulnerable to short sellersJuly 2025 Chart Watch & Smart Investment Allocation Tips - khodrobank.com
What moving averages say about NextCure Inc.July 2025 Pullbacks & High Yield Stock Recommendations - Newser
Applying Wyckoff theory to NextCure Inc. stockWeekly Gains Summary & Weekly Sector Rotation Insights - Newser
Activity Recap: Can NextCure Inc. disrupt its industryJuly 2025 Final Week & Consistent Return Strategy Ideas - khodrobank.com
Is NextCure Inc. stock a good dividend stockJuly 2025 Big Picture & High Accuracy Investment Signals - khodrobank.com
US Market Recap: Will NextCure Inc. outperform tech stocks2025 Technical Patterns & Community Verified Swing Trade Signals - khodrobank.com
Using AI based signals to follow NextCure Inc.July 2025 Trade Ideas & AI Enhanced Execution Alerts - Newser
Should you wait for a breakout in NextCure Inc.2025 Top Decliners & Technical Confirmation Trade Alerts - Newser
Aug Wrap: Is NextCure Inc.’s ROE strong enoughRisk Management & Reliable Breakout Forecasts - khodrobank.com
Is NextCure Inc.’s ROE strong enoughJuly 2025 Update & High Conviction Trade Alerts - khodrobank.com
NextCure : September 2025 Corporate Presentation - MarketScreener
What Technical Tools Say About NextCure Inc. RecoveryMarket Activity Report & High Yield Equity Trading Tips - beatles.ru
Advanced analytics toolkit walkthrough for NextCure Inc.July 2025 Spike Watch & Weekly Chart Analysis and Trade Guides - Newser
Top chart patterns to watch in NextCure Inc.Earnings Risk Report & Fast Momentum Entry Tips - Newser
Visualizing NextCure Inc. stock with heatmapsWeekly Market Report & Accurate Intraday Trading Signals - Newser
How NextCure Inc. stock performs during market volatility2025 Technical Overview & Technical Pattern Alert System - Newser
NextCure’s Chief Scientific Officer Resigns - MSN
Nextcure Inc (NXTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.75%
1.11%
자본화:
|
볼륨(24시간):